Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

REVB Revelation Biosciences Inc

2,0522

0,0622 (3,13%)

Zuletzt aktualisiert: 17:32:35

Verzögert um 15 Minuten

Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Revelation Biosciences (NASDAQ:REVB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Revelation Biosciences Charts.

Revelation Biosciences (NASDAQ:REVB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Revelation Biosciences Charts.

News Revelation Biosciences Inc

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
Freitag 10 Mai 2024 (2 Wochen vor) • Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
Freitag 22 März 2024 (2 Monate vor) • Business Wire

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
Mittwoch 13 März 2024 (2 Monate vor) • Business Wire

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
Dienstag 12 März 2024 (2 Monate vor) • Business Wire

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
Montag 4 März 2024 (3 Monate vor) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
Dienstag 13 Februar 2024 (3 Monate vor) • Business Wire

Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Montag 12 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 8 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
Montag 5 Februar 2024 (3 Monate vor) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 2 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
Donnerstag 1 Februar 2024 (4 Monate vor) • Business Wire

Weitere Revelation Biosciences Inc News-Artikel

M.DIAS BRANCO ON

Crossroads Impact

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen